ReCode Raises Another $120m To Broaden LNP Delivery Of Genetic Medicines

Initial $80m Series B From October Increased To $200m

 
• By Mandy Jackson
  
Genetic background with DNA strand. DNA spirals on a blue background.
ReCode also will expand its LNP delivery of genetic medicines to organs beyond the lungs • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Financing

More from Business